drugset / Trial / NCT03617783
Prebiotic Treatment in People With Schizophrenia - Pilot Study
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to examine changes in serum butyrate levels with the prebiotic: Prebiotin (12g/day), an oligofructose-enriched inulin (OEI); the effect of OEI on the composition of the gastrointestinal microbiota in people with schizophrenia; and the relationship of the composition of the gut microbiota to various clinical, cognitive, and neuroimaging variables.
Timeline
- Start
- 2019-07-18
- Primary completion
- 2022-04-05
- Completion
- 2022-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prebiotin | Other / unclassified | 4 g | — |